LncRNA PCGEM1 in Human Cancers: Functions, Mechanisms and Promising Clinical Utility

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• Long noncoding RNAs (lncRNAs) are key regulators of gene expression, impacting processes like chromosome remodeling and transcription.
• Dysregulation of lncRNAs is increasingly associated with human diseases, particularly various cancers.
• Prostate Gene Expression Marker 1 (PCGEM1) is a lncRNA implicated in the initiation and progression of multiple tumors.

Purpose of the Study:

• To review recent studies on lncRNA PCGEM1 expression in human cancers.
• To comprehensively describe the regulatory mechanisms of PCGEM1 in tumor development.
• To highlight the potential clinical applications of PCGEM1 in cancer diagnosis, prognosis, and therapy.

Main Methods:

• Retrospective review of published literature on PCGEM1 and cancer.
• Analysis of studies detailing PCGEM1's interaction with tumor-related signaling pathways.
• Synthesis of evidence regarding PCGEM1's role in cancer initiation, progression, and clinical relevance.

Main Results:

• PCGEM1 expression is dysregulated in various human cancers.
• PCGEM1 interacts with critical regulators in tumor-associated signaling pathways.
• Evidence suggests PCGEM1 influences tumor initiation and progression.

Conclusions:

• lncRNA PCGEM1 plays a significant role in multiple cancers.
• Understanding PCGEM1's mechanisms offers insights into tumor biology.
• PCGEM1 holds potential as a biomarker and therapeutic target for cancer treatment.